AU733590B2 - O2-arylated or o2-glycosylated 1-substituted diaze n-1-ium-1,2-diolates and o2-substituted 1-((2-carboxylato)pyrrolidin-1-yl)diazen-1-ium-1,2- diolates - Google Patents
O2-arylated or o2-glycosylated 1-substituted diaze n-1-ium-1,2-diolates and o2-substituted 1-((2-carboxylato)pyrrolidin-1-yl)diazen-1-ium-1,2- diolates Download PDFInfo
- Publication number
- AU733590B2 AU733590B2 AU45957/97A AU4595797A AU733590B2 AU 733590 B2 AU733590 B2 AU 733590B2 AU 45957/97 A AU45957/97 A AU 45957/97A AU 4595797 A AU4595797 A AU 4595797A AU 733590 B2 AU733590 B2 AU 733590B2
- Authority
- AU
- Australia
- Prior art keywords
- diazeniumdiolate
- group
- substituted
- aryl
- chain alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
- C07C291/08—Azoxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
- C07D295/30—Nitrogen atoms non-acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2681696P | 1996-09-27 | 1996-09-27 | |
US60/026816 | 1996-09-27 | ||
US4591797P | 1997-05-07 | 1997-05-07 | |
US60/045917 | 1997-05-07 | ||
US5169697P | 1997-07-03 | 1997-07-03 | |
US60/051696 | 1997-07-03 | ||
PCT/US1997/017267 WO1998013358A1 (en) | 1996-09-27 | 1997-09-26 | O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4595797A AU4595797A (en) | 1998-04-17 |
AU733590B2 true AU733590B2 (en) | 2001-05-17 |
Family
ID=27362853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45957/97A Expired AU733590B2 (en) | 1996-09-27 | 1997-09-26 | O2-arylated or o2-glycosylated 1-substituted diaze n-1-ium-1,2-diolates and o2-substituted 1-((2-carboxylato)pyrrolidin-1-yl)diazen-1-ium-1,2- diolates |
Country Status (7)
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2794647A1 (fr) * | 1999-06-11 | 2000-12-15 | Centre Nat Rech Scient | Compositions pharmaceutique comprenant du no ou au moins un compose capable de liberer ou d'induire la formation de no dans les cellules |
US7678391B2 (en) | 2000-04-26 | 2010-03-16 | Queen's University At Kingston | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
JP2003531179A (ja) | 2000-04-26 | 2003-10-21 | クイーンズ ユニバーシティ アット キングストン | 悪性細胞表現型に対し一酸化窒素模倣体を使用する処方および方法 |
US20020064802A1 (en) * | 2000-04-28 | 2002-05-30 | Eva Raschke | Methods for binding an exogenous molecule to cellular chromatin |
WO2001092215A2 (en) * | 2000-06-02 | 2001-12-06 | Us Health | Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same |
WO2002041902A1 (en) * | 2000-11-27 | 2002-05-30 | The University Of Akron | Treatment of disorders using polyethylenimine diazeniumdiolate |
CA2480033C (en) * | 2002-03-21 | 2011-05-10 | The University Of Utah Research Foundation | In vivo use of glutathionone s-transferase activated nitric oxide donors |
EP1507526A2 (en) | 2002-05-07 | 2005-02-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
EP1545798A4 (en) * | 2002-08-02 | 2006-06-14 | Us Gov Health & Human Serv | NETWORKED NITROGEN OXIDE RELEASING POLYAMINE-COATED SUBSTRATES, THESE COMPOSITIONS AND MANUFACTURING PROCESSES DAF R |
WO2005011575A2 (en) * | 2003-07-25 | 2005-02-10 | The University Of Akron | Stabilization and ionic triggering of nitric oxide release |
CA2554771A1 (en) * | 2004-01-30 | 2005-08-18 | Johns Hopkins University | Nitroxyl progenitor compounds and methods of use |
CA2555591C (en) * | 2004-02-09 | 2011-01-04 | Amulet Pharmaceuticals, Inc. | Nitric oxide-releasing polymers |
US7569559B2 (en) | 2004-02-09 | 2009-08-04 | Noxilizer, Inc. | Nitric oxide-releasing molecules |
WO2005105171A1 (en) * | 2004-04-29 | 2005-11-10 | Cube Medical A/S | A balloon for use in angioplasty with an outer layer of nanofibers |
US20050265958A1 (en) * | 2004-05-14 | 2005-12-01 | West Jennifer L | Nitric oxide releasing compositions and associated methods |
CA2581939C (en) | 2004-09-27 | 2013-01-08 | Joseph A. Hrabie | Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof |
EP3556401A1 (en) | 2005-05-27 | 2019-10-23 | The University of North Carolina at Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
US8021679B2 (en) | 2005-08-25 | 2011-09-20 | Medtronic Vascular, Inc | Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
WO2007053292A2 (en) * | 2005-10-31 | 2007-05-10 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
EP1968615A4 (en) * | 2005-12-06 | 2010-08-04 | Amulet Pharmaceuticals Inc | POLYMERS RELEASING NITRIC OXIDE |
AU2007244903B2 (en) * | 2006-04-24 | 2012-02-02 | The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services | Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
US8241619B2 (en) | 2006-05-15 | 2012-08-14 | Medtronic Vascular, Inc. | Hindered amine nitric oxide donating polymers for coating medical devices |
US7811600B2 (en) * | 2007-03-08 | 2010-10-12 | Medtronic Vascular, Inc. | Nitric oxide donating medical devices and methods of making same |
FR2916757B1 (fr) * | 2007-05-30 | 2009-07-17 | Servier Lab | Nouveaux derives diazeniumdiolates,leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US8273828B2 (en) * | 2007-07-24 | 2012-09-25 | Medtronic Vascular, Inc. | Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation |
US20090222088A1 (en) * | 2008-02-29 | 2009-09-03 | Medtronic Vascular, Inc. | Secondary Amine Containing Nitric Oxide Releasing Polymer Composition |
CA2717867C (en) | 2008-03-07 | 2017-05-30 | Paul J. Shami | Activated nitric oxide donors and methods of making and using thereof |
US20090232863A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers |
US20090232868A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Nitric Oxide Releasing Polymer Composition |
US8852640B2 (en) * | 2008-07-03 | 2014-10-07 | Ecole Polytechnique Federale De Lausanne (Epfl) | Micelles for delivery of nitric oxide |
US8158187B2 (en) * | 2008-12-19 | 2012-04-17 | Medtronic Vascular, Inc. | Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
US8709465B2 (en) * | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
WO2011022652A1 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Topical gels |
BR112012003804B1 (pt) | 2009-08-21 | 2019-02-19 | Novan, Inc. | Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento |
EP2498778A1 (en) * | 2009-11-13 | 2012-09-19 | The United States Of America, As Represented By The Secretary, Department of Health and Human Services | Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
RU2012138955A (ru) | 2010-02-12 | 2014-03-20 | Мерк Шарп Энд Домэ Корп. | Циклопентилпроизводные диазенийдиолата |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
WO2012118829A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same |
US9187501B2 (en) | 2012-08-28 | 2015-11-17 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing nanorods and their methods of use |
CN106459668A (zh) * | 2014-04-16 | 2017-02-22 | Sika技术股份公司 | 基于含硅烷基团的有机聚合物的迅速固化的无迁移组合物 |
US11186640B2 (en) * | 2014-07-31 | 2021-11-30 | The University Of Western Australia | Method for the identification of immunotherapy-drug combinations using a network approach |
JP6661289B2 (ja) * | 2015-07-08 | 2020-03-11 | 三星ディスプレイ株式會社Samsung Display Co.,Ltd. | 有機エレクトロルミネッセンス素子用材料及びそれを用いた有機エレクトロルミネッセンス素子 |
WO2017075460A1 (en) * | 2015-10-29 | 2017-05-04 | Arizona Board Of Regents On Behalf Of Arizona State University | Skin-like condoms having active ingredients to enhance a male erection and a female arousal |
WO2018067838A1 (en) | 2016-10-07 | 2018-04-12 | The University Of North Carolina At Chapel Hill | S-nitrosothiol-mediated hyperbranched polyesters |
WO2018127819A1 (en) | 2017-01-03 | 2018-07-12 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto |
CA3055474A1 (en) | 2017-03-28 | 2018-10-04 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto |
JP2021515083A (ja) * | 2018-03-06 | 2021-06-17 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルThe University Of North Carolina At Chapel Hill | 生分解性の抗菌性足場としての一酸化窒素放出性シクロデキストリンおよびそれに関する方法 |
US11421044B2 (en) | 2018-12-28 | 2022-08-23 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3153094A (en) | 1959-06-10 | 1964-10-13 | Du Pont | Nitrosamine manufacture |
US4954526A (en) | 1989-02-28 | 1990-09-04 | The United States Of America As Represented By The Department Of Health And Human Services | Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents |
US5208233A (en) | 1989-09-15 | 1993-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5039705A (en) * | 1989-09-15 | 1991-08-13 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5721365A (en) * | 1989-09-15 | 1998-02-24 | Us Health | N-substituted piperazine NONOates |
US5212204A (en) | 1989-10-18 | 1993-05-18 | The United States Of America As Represented By The Department Of Health And Human Services | Antihypertensive compositions and use thereof |
US5155137A (en) | 1990-09-20 | 1992-10-13 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Complexes of nitric oxide with polyamines |
WO1993007114A1 (en) | 1991-09-24 | 1993-04-15 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs |
US5389675A (en) | 1992-03-27 | 1995-02-14 | The United States Of America As Represented By The Department Of Health And Human Services | Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
US5525357A (en) | 1992-08-24 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US5405919A (en) | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US5691423A (en) | 1992-08-24 | 1997-11-25 | The United States Of America As Represented By The Department Of Health And Human Services | Polysaccharide-bound nitric oxide-nucleophile adducts |
US5632981A (en) | 1992-08-24 | 1997-05-27 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US5700830A (en) * | 1994-11-22 | 1997-12-23 | The United States Of America As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents for reducing metastasis risk |
US5714511A (en) * | 1995-07-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
-
1997
- 1997-09-26 US US09/254,301 patent/US6610660B1/en not_active Expired - Lifetime
- 1997-09-26 EP EP97944471A patent/EP0929538B1/en not_active Expired - Lifetime
- 1997-09-26 DE DE69731758T patent/DE69731758T2/de not_active Expired - Lifetime
- 1997-09-26 AU AU45957/97A patent/AU733590B2/en not_active Expired
- 1997-09-26 AT AT97944471T patent/ATE283267T1/de not_active IP Right Cessation
- 1997-09-26 WO PCT/US1997/017267 patent/WO1998013358A1/en active IP Right Grant
- 1997-09-26 CA CA2266908A patent/CA2266908C/en not_active Expired - Lifetime
- 1997-09-26 CA CA2705474A patent/CA2705474C/en not_active Expired - Lifetime
- 1997-09-26 EP EP10010885.1A patent/EP2292630B1/en not_active Expired - Lifetime
-
2003
- 2003-01-07 US US10/337,495 patent/US6911433B2/en not_active Expired - Lifetime
-
2005
- 2005-04-12 US US11/104,232 patent/US7081524B2/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
J.CHEM SOC PERKIN TRANS I (1982) PAGES 2139-2147 * |
J.CHEM SOC PERKIN TRANS II (1986) PAGES 689-693 * |
RUSSIAN CHEMICAL BULLETIN VOL 44 NO11 (1995) PAGES 2183-2185 * |
Also Published As
Publication number | Publication date |
---|---|
US6610660B1 (en) | 2003-08-26 |
EP0929538B1 (en) | 2004-11-24 |
US6911433B2 (en) | 2005-06-28 |
US20030147845A1 (en) | 2003-08-07 |
US20050214249A1 (en) | 2005-09-29 |
DE69731758T2 (de) | 2005-12-15 |
CA2705474A1 (en) | 1998-04-02 |
CA2266908C (en) | 2010-07-20 |
DE69731758D1 (de) | 2004-12-30 |
CA2705474C (en) | 2013-07-16 |
WO1998013358A1 (en) | 1998-04-02 |
EP2292630B1 (en) | 2015-11-25 |
EP2292630A1 (en) | 2011-03-09 |
AU4595797A (en) | 1998-04-17 |
CA2266908A1 (en) | 1998-04-02 |
EP0929538A1 (en) | 1999-07-21 |
ATE283267T1 (de) | 2004-12-15 |
US7081524B2 (en) | 2006-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU733590B2 (en) | O2-arylated or o2-glycosylated 1-substituted diaze n-1-ium-1,2-diolates and o2-substituted 1-((2-carboxylato)pyrrolidin-1-yl)diazen-1-ium-1,2- diolates | |
Aggarwal et al. | Synthesis and biological evaluation of prodrugs of zidovudine | |
JP5015903B2 (ja) | O2−グリコシル化1−置換ジアゼン−1−イウム−1,2−ジオレート類およびそのようなジオレート類を含有する組成物 | |
Pan et al. | Development of 5-Fluorouracil derivatives as anticancer agents | |
US3666856A (en) | Treating immune response with amino purine derivatives | |
WO2006032921A1 (en) | Bioreductively-activated prodrugs | |
WO2001092215A2 (en) | Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same | |
US4081534A (en) | Amino purine nucleosides as autoimmune suppressant agents | |
Lin et al. | Synthesis and antiviral activity of several 2, 5'-anhydro analogs of 3'-azido-3'-deoxythymidine (AZT), 3'-azido-2', 3'-dideoxyuridine (AZU), 3'-azido-2', 3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus (HIV-1) and Rauscher-Murine leukemia virus (R-MuLV) | |
CA1265139A (en) | Amides and ester of 2-¬n-(morpholinoalkyl) aminosulfonyl|-nitrobenzoic acids, useful as adjuncts to radiation therapy | |
EP1439187B1 (en) | O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates | |
CA2814748C (en) | O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates | |
Lown et al. | Novel antitumor nitrosoureas and related compounds and their reactions with DNA | |
Al-Abed et al. | Inhibition of HIV-1 nuclear import via Schiff base formation with arylene bis (methylketone) compounds | |
RU2418795C2 (ru) | Производные диоксолана для лечения рака | |
RU2187509C1 (ru) | Производные 5'-h-фосфоната 3'-азидо-3'-дезокситимидина и фармацевтические композиции на их основе | |
Piper et al. | Synthesis of potential inhibitors of hypoxanthine-guanine phosphoribosyltransferase for testing as antiprotozoal agents. 2. 1-Substituted hypoxanthines | |
US4720497A (en) | 6-purinyl N-/2-chloroethyl/carbamate and thiocarbamate and process for the preparation thereof | |
Al-Masoudi et al. | Synthesis and Biological Activity of Some 5-Substituted-6-azauracil-N-1-nucleosides of 2-Acetamido-2-deoxy-D-glucose | |
KR870001935B1 (ko) | 항포진성을 갖는 뉴클레오시 유도체 및 그의 산부가염의 제조방법 | |
LV11542B (en) | Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof | |
Lin et al. | Syntheses of [2‐14C] 2, 5′‐anhydro‐3′‐azido‐3′‐deoxythymidine and [2‐14C] 2, 5′‐anhydro‐3′‐azido‐2′, 3′‐dideoxy‐5‐iodouridine: Inhibitors of human immunodeficiency virus (HIV‐1) | |
Leites et al. | Synthesis and evaluation trypanosomicidal activity of new derivatives of megazol | |
AU721747B2 (en) | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide | |
WO1990004969A1 (en) | Novel azt analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |